Hypothalamic adipsia presenting as persistent hypernatremia after aneurysmal subarachnoid hemorrhage.
Hypernatremia after subarachnoid hemorrhage should not be automatically attributed to AVP deficiency; hypothalamic adipsia may also be a contributing factor.
Where it sits
this study against the rest of the desmopressin corpusSummary and findings
A woman in her 50s developed persistent hypernatremia after aneurysmal subarachnoid hemorrhage treated with surgical clipping. Initially, she required desmopressin due to transient hypotonic polyuria, suggesting arginine vasopressin deficiency. However, her clinical course indicated hypothalamic adipsia rather than persistent AVP deficiency.
Abstract
A woman in her 50s developed persistent hypernatremia after aneurysmal subarachnoid hemorrhage treated with surgical clipping. During the acute phase, she presented transient hypotonic polyuria requiring desmopressin, initially suggesting arginine vasopressin (AVP) deficiency (AVP-D). However, her subsequent course was characterized by recurrent hypernatremia without persistent polyuria and with complete absence of thirst. Urine output was low or inappropriately normal, with preserved urinary concentrating capacity, making persistent AVP-D unlikely. Neuroimaging showed ischemic changes close to hypothalamic regions involved in osmoregulation. The clinical pattern supported hypothalamic adipsia, with possible partial dysfunction of osmotically stimulated AVP release. Outpatient management focused on structured water intake, family supervision, digital reminder systems, and cautious low-dose desmopressin to minimize osmotic variability. This case emphasizes that hypernatremia following neurovascular injury should not be automatically attributed to AVP-D. Systematic assessment of thirst, urine output, and urine osmolality is key to identifying hypothalamic adipsia, facilitating early diagnosis and the implementation of structured hydration strategies to prevent recurrent severe hypernatremia and its complications.
Background
This paper addresses the clinical issue of hypernatremia following aneurysmal subarachnoid hemorrhage, a condition that can complicate recovery. Prior knowledge indicates that arginine vasopressin deficiency is a common cause of hypernatremia, but this case suggests that hypothalamic adipsia may also play a significant role. Understanding the underlying mechanisms is crucial for effective management and prevention of complications.
Methods
This case report describes a single patient who developed persistent hypernatremia after surgical clipping for aneurysmal subarachnoid hemorrhage. The patient was treated with desmopressin during the acute phase due to transient hypotonic polyuria. The assessment included neuroimaging and evaluation of thirst, urine output, and urine osmolality to differentiate between AVP deficiency and hypothalamic adipsia.
Results
The patient exhibited persistent hypernatremia without persistent polyuria and a complete absence of thirst. Urine output was noted to be low or inappropriately normal, with preserved urinary concentrating capacity. Neuroimaging revealed ischemic changes near hypothalamic regions involved in osmoregulation, supporting the diagnosis of hypothalamic adipsia.
Interpretation
This case highlights the importance of differentiating between AVP deficiency and hypothalamic adipsia in patients with hypernatremia following neurovascular injury. While the findings are significant, the clinical implications may be limited due to the small sample size and lack of quantitative data. The evidence suggests that structured hydration strategies are essential for managing such cases effectively.
Key findings
- Persistent hypernatremia observed after aneurysmal subarachnoid hemorrhage.
- Transient hypotonic polyuria required desmopressin during the acute phase.
- Urine output was low or inappropriately normal with preserved urinary concentrating capacity.
- Neuroimaging showed ischemic changes close to hypothalamic regions involved in osmoregulation.
Limitations
- Single case report limits generalizability.
- No quantitative data on desmopressin effectiveness.
- Short-term follow-up may not capture long-term outcomes.
- No control group for comparison.